AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,701,000 | -45.7% | 1,102,735 | 0.0% | 4.95% | -22.0% |
| Q4 2015 | $10,498,000 | -7.9% | 1,102,735 | -20.2% | 6.34% | +117.2% |
| Q3 2015 | $11,394,000 | -49.3% | 1,382,735 | 0.0% | 2.92% | -53.9% |
| Q2 2015 | $22,455,000 | -59.9% | 1,382,735 | 0.0% | 6.33% | -50.9% |
| Q1 2015 | $56,029,000 | -23.3% | 1,382,735 | 0.0% | 12.90% | -35.8% |
| Q4 2014 | $73,076,000 | +70.6% | 1,382,735 | 0.0% | 20.10% | +4.4% |
| Q3 2014 | $42,833,000 | – | 1,382,735 | – | 19.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|